SG Americas Securities LLC boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 118.3% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 4,888 shares of the insurance provider’s stock after buying an additional 2,649 shares during the quarter. SG Americas Securities LLC’s holdings in Humana were worth $2,023,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Morgan Stanley boosted its position in shares of Humana by 1.5% in the first quarter. Morgan Stanley now owns 332,161 shares of the insurance provider’s stock worth $104,305,000 after purchasing an additional 4,850 shares during the period. Assenagon Asset Management S.A. bought a new position in shares of Humana in the second quarter worth approximately $861,000. Cerebellum GP LLC bought a new position in shares of Humana in the second quarter worth approximately $26,000. CWM LLC boosted its position in shares of Humana by 19.4% in the second quarter. CWM LLC now owns 166 shares of the insurance provider’s stock worth $64,000 after purchasing an additional 27 shares during the period. Finally, Duncker Streett & Co. Inc. bought a new position in shares of Humana in the second quarter worth approximately $58,000. Institutional investors own 92.43% of the company’s stock.

HUM has been the topic of several research analyst reports. ValuEngine raised shares of Humana from a “sell” rating to a “hold” rating in a report on Wednesday, September 2nd. Piper Sandler boosted their target price on shares of Humana from $473.00 to $495.00 and gave the stock an “overweight” rating in a report on Thursday, October 1st. Credit Suisse Group boosted their target price on shares of Humana from $423.00 to $465.00 and gave the stock an “outperform” rating in a report on Wednesday, November 4th. SVB Leerink boosted their target price on shares of Humana from $465.00 to $496.00 and gave the stock an “outperform” rating in a report on Thursday, August 6th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Humana from $394.00 to $452.00 and gave the stock an “overweight” rating in a report on Tuesday, August 18th. Eight analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $447.35.

Shares of NYSE:HUM opened at $406.21 on Friday. The company has a market capitalization of $53.76 billion, a price-to-earnings ratio of 13.02, a price-to-earnings-growth ratio of 1.96 and a beta of 0.94. Humana Inc. has a 52 week low of $208.25 and a 52 week high of $474.70. The company has a quick ratio of 1.69, a current ratio of 1.81 and a debt-to-equity ratio of 0.38. The firm has a 50 day moving average of $426.69 and a 200 day moving average of $404.01.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, November 3rd. The insurance provider reported $3.08 EPS for the quarter, topping analysts’ consensus estimates of $2.81 by $0.27. The company had revenue of $20.08 billion during the quarter, compared to the consensus estimate of $18.59 billion. Humana had a net margin of 5.58% and a return on equity of 22.74%. Humana’s revenue for the quarter was up 23.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.03 earnings per share. On average, sell-side analysts expect that Humana Inc. will post 18.74 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 31st will be paid a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date is Wednesday, December 30th. Humana’s dividend payout ratio (DPR) is 13.99%.

Humana Company Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Further Reading: Understanding the two types of arbitrage

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.